Next Article in Journal
CCR6 Deficiency Increases Infarct Size after Murine Acute Myocardial Infarction
Next Article in Special Issue
Novel Nematode-Killing Protein-1 (Nkp-1) from a Marine Epiphytic Bacterium Pseudoalteromonas tunicata
Previous Article in Journal
DNA Methylation Signature in Mononuclear Cells and Proinflammatory Cytokines May Define Molecular Subtypes in Sporadic Meniere Disease
Previous Article in Special Issue
Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach
Review

Oral Mucositis in Cancer and Potential Use of Omega-3 Free Fatty Acids in Its Management: A Review

1
School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland 1142, New Zealand
2
Department of Stomatology, A.C. Camargo Cancer Center, FO-USP, São Paulo 01525-001, Brazil
3
School of Public Health and Interdisciplinary Studies, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland 1142, New Zealand
4
College of Food Engineering and Nutrition Sciences, Shaanxi Normal University, Xi’an 710119, China
5
College of Food Science and Technology, Nanchang University, Nanchang 330031, China
6
Maurice Wilkins Centre for Molecular Discovery, Auckland 1010, New Zealand
*
Author to whom correspondence should be addressed.
Academic Editors: Amirata Saei Dibavar and Yoshihiro Abiko
Biomedicines 2021, 9(11), 1531; https://doi.org/10.3390/biomedicines9111531
Received: 15 August 2021 / Revised: 18 October 2021 / Accepted: 19 October 2021 / Published: 25 October 2021
(This article belongs to the Special Issue Biomedicine from the Sea)
Oral mucositis (OM) is a painful condition caused by chemotherapeutic or radiotherapeutic cancer treatments, occurring in patients with different tumour characteristics and locations. OM greatly impacts a patient’s quality of life and cancer recovery. Current OM management strategies are not providing sufficient prevention and treatment; new approaches to injury management are needed. Studies on the benefit of omega-3 free fatty acids (FFA) in human health have increased significantly in recent years. FFA properties have been studied extensively, including their potential therapeutic use in inflammatory conditions. However, omega-3 FFA’s use as a supplementary treatment for OM has not been clinically tested. Preliminary evidence suggests that utilising FFA to manage OM could be a useful strategy for lesion management, assisting with healthy oral mucosa recovery. This review will describe the incidence, risk factors, biology of OM and the current treatment strategies, leading to a discussion of the utility of omega-3 FFA as a novel therapeutic agent for OM. View Full-Text
Keywords: oral mucositis; inflammation; polyunsaturated fatty acids; omega-3 fatty acids; omega-6 fatty acids; cancer; prostaglandins; leukotrienes; interleukins; cytokines oral mucositis; inflammation; polyunsaturated fatty acids; omega-3 fatty acids; omega-6 fatty acids; cancer; prostaglandins; leukotrienes; interleukins; cytokines
Show Figures

Figure 1

MDPI and ACS Style

Lessa, R.C.; Alves, F.d.A.; Fortunati, E.; Lu, J. Oral Mucositis in Cancer and Potential Use of Omega-3 Free Fatty Acids in Its Management: A Review. Biomedicines 2021, 9, 1531. https://doi.org/10.3390/biomedicines9111531

AMA Style

Lessa RC, Alves FdA, Fortunati E, Lu J. Oral Mucositis in Cancer and Potential Use of Omega-3 Free Fatty Acids in Its Management: A Review. Biomedicines. 2021; 9(11):1531. https://doi.org/10.3390/biomedicines9111531

Chicago/Turabian Style

Lessa, Roberta C., Fabio d.A. Alves, Erika Fortunati, and Jun Lu. 2021. "Oral Mucositis in Cancer and Potential Use of Omega-3 Free Fatty Acids in Its Management: A Review" Biomedicines 9, no. 11: 1531. https://doi.org/10.3390/biomedicines9111531

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop